AHNTI EU (Animal Health, Nutrition & Technology Innovation) has announced the 2026 Innovation Showcase finalists, a curated group of early-stage companies identified as the “ones to watch” across biopharma, nutrition, technology and diagnostics.
Selected by AHNTI’s committee of investors and industry leaders, these finalists will take to the stage on 2 March 2026 in London at Convene St Paul’s, and pitch live during AHNTI EU 2026 to an audience of industry leaders, investors, pharma, biotech, CDMOs, and strategic partners.
The 2026 AHNTI EU Innovation Showcase finalists
Biopharma
BioAZ – Biotechnology company advancing animal health and welfare through high-impact scientific solutions.
Modulant Bioscience – Small molecule therapeutics targeting multiprotein complexes involved in infectious and chronic disease.
NanoVet Biotech – Camelid-derived nanobodies and biologics with programs spanning dermatology, cancer therapies, osteoarthritis, and kidney disease.
Pasture Biosciences – Developing next-generation veterinary vaccines including a cattle vaccine aiming to improve feed efficiency and reduce methane emissions.
Nutrition
Agteria Biotech – Developing a methane-reducing compound for cattle to help cut agricultural emissions while maintaining health and productivity.
NanosVet – Needle-free medicine through dissolvable oral nanostrips, launching with an epi-pen equivalent for pets.
Pet Diet Plans – Personalised diet plans and practical nutrition support for long-term pet wellness and quality of life.
PhageLab – Bacteriophage-based solutions supporting alternatives to antibiotics and addressing antimicrobial resistance.
Technology
Athian – Carbon marketplace for livestock to aggregate, verify, and monetize on-farm greenhouse gas reductions.
MariHealth Solutions – Bioinformatics and deep data analytics turning biological data into actionable insights for animal health and nutrition.
Photon Therapeutics – Ophthalmic research and clinical science collaboration developing compliant, patient-focused solutions.
Vet Vision AI – AI-driven machine vision and real-time monitoring for welfare, behaviour, and health insights to support earlier intervention.
Diagnostics
PrediPet – Simple blood test to detect, monitor, and screen for cancer and tumour-related disease in dogs.
InsituGen – Patented bioassay technology measuring steroid hormone bioactivity for sensitive, non-targeted screening.
Pictor – Multiplex proteomics and ELISA-based testing for human and animal health with faster turnaround and lower cost.
Pronova – At-home saliva-based biosensor platform for dogs delivering biomarker insights in ~15 minutes via mobile app.
AHNTI EU believes that innovation is reshaping the future of animal health, accelerating earlier diagnosis, improving welfare outcomes, advancing sustainability in food systems, and enabling new therapeutic and preventive solutions at scale.
“As global challenges continue to grow across companion animal care and livestock production alike, the need for breakthrough thinking and investable innovation has never been greater,” says the company.
